← Back to headlines
H.C. Wainwright Bullish on SAB Biotherapeutics with $10 Price Target
H.C. Wainwright expresses a bullish outlook on SAB Biotherapeutics (SABS), setting a $10 price target for the company's stock.
5 Jul, 22:08 — 5 Jul, 22:08
Sources
Showing 1 of 1 sources
